The 12th Annual Angioma Alliance Cerebral Cavernous Malformations (CCM) Scientific Meeting

脑海绵状血管畸形(CCM)是一种中枢神经系统的血管疾病 导致严重神经系统症状、癫痫发作和/或出血性中风的系统 由于脑部和脊髓血管病变的发展。近年来， 疾病的机制已经变得更加明确，候选药物也越来越多。 分子正在接受研究。然而，仍然有一个尚未满足的临床需求 病人。血管瘤联盟是非营利性的患者权益倡导组织 由CCM提供。血管瘤联盟主办CCM年度会议系列会议，目标是 促进研究的快速进展，以全面了解该病和 一种药物疗法的发展。主办本系列的主要目标是提供 一个多学科数据展示和利益攸关方讨论的论坛， 这项提案的目的是要求部分资金来增加和扩大 第12届CCM科学年会的出席情况。具体来说，我们的目标是增加 参加培训的学员、代表不足的少数族裔和临床医生的数量 提供旅行援助以及有针对性的广告和邀请函投放策略。 此外，我们打算通过主办一次主持小组讨论来扩大科学多样性。 浅议CCM病变与肿瘤生物学的关系及普遍关注 关于血管畸形动物研究和治疗策略的主题演讲。 鉴于过去几年对CCM疾病的了解取得了进展，参加 这次会议对所有利益相关者了解最新研究情况至关重要。 发展，并参与独特的合作努力。

Cerebral Cavernous Malformations (CCM) is a vascular disorder of the central nervous system that causes serious neurological symptoms, seizures and/or hemorrhagic stroke due to the development of vascular lesions in the brain and spinal cord. In recent years, the mechanism of disease has become better defined and numerous candidate drug molecules are under investigation. However, there remains an unmet clinical need for patients. Angioma Alliance is the non-profit Patient Advocacy Group for those affected by CCM. Angioma Alliance hosts the annual CCM Meeting series with the goal of facilitating rapid research progress toward a complete understanding of the disease and development of a drug therapy. The primary objective in hosting this series is to provide a forum for multi-disciplinary data presentation and discussion between stakeholders, and the purpose of this proposal is to request partial funding to increase and broaden the attendance at the 12th annual CCM Scientific Meeting. Specifically, we aim to increase the number of trainees, underrepresented minorities and clinicians in attendance by providing travel assistance and targeted advertising and invitation delivery strategies. Furthermore, we intend to broaden scientific diversity by hosting a moderated panel discussion on the relationship of CCM lesion to cancer biology, and a general interest keynote address on vascular malformation animal research and therapeutic strategies. Given the advances in understanding the CCM illness over the past few years, attending this meeting is critical for all stakeholders to stay abreast of the latest research developments and to participate in unique collaborative endeavors.